“Those of us in the melanoma business have felt like we've ... experience progression of their cancers initially, followed by regression, and that other patients have most of their lesions ...
Thus, the demonstration that IL-2 administration could reproducibly mediate tumor regression in 15−20% of patients with metastatic melanoma or renal-cell cancer established, for the first time ...
Investigators identified six high-risk clusters, seven low-risk clusters, and one outlier of melanoma incidence. Adjusted spatial regression identified that for every one-minute increase in ...